相关实验视频

Updated: Jul 13, 2025

In vitro Functional Characterization of Mouse Colorectal Afferent Endings

In vitro Functional Characterization of Mouse Colorectal Afferent Endings

Published on: January 21, 2015

在患有刺激性肠综合征的患者中对敏感

Süleyman Coşgun¹, Umut Polat², Muhammed Kaya³

¹Internal Medicine, Gastroenterology, Kütahya University of Health Sciences, Kütahya, TUR.

|October 16, 2023

概括

发现,与健康人相比,患有刺激性肠综合征 (IBS) 的患者对常见过敏原的敏感性显著更高. 这表明过敏和IBS发展之间存在潜在的联系.

科学领域:

皮肤病学皮肤病学
胃肠病学胃肠病学
过敏学过敏学

背景情况:

(Ni) 是一个常见的接触过敏原.
刺激性肠综合征 (IBS) 影响了人口的很大一部分.
尼子敏感性和IBS之间的潜在联系尚未得到充分证实.

研究的目的:

调查Ni敏感性和IBS之间的关联.
为了确定NI过敏是否在IBS患者中比一般人群更常见.

主要方法:

一项涉及50名IBS患者和40名健康对照者的病例控制研究.
使用欧洲标准接触过敏原系列的补丁测试.
应用后48,72和96小时对贴片试验反应的评估.

主要成果:

在40%的IBS患者中检测到敏感性,而对照组中只有17.5% (p=0.03).
该研究包括了IBS患者的平均年龄约为43岁和对照组的平均年龄为40岁的参与者.
在IBS队列中观察到Ni过敏的更高患病率.

结论:

尼克尔敏感性似乎在IBS患者中明显更为普遍.
这些发现表明,Ni敏感性可能在IBS的发病过程中发挥作用.
需要进一步的研究来探索Ni敏感性-IBS连接背后的机制.

关键词:

接触过敏原的接触过敏原接触性皮肤炎刺激性肠综合征 (IBS) 是一种尼克尔尼克尔是什么意思尼克尔的灵敏度是什么

更多相关视频

Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform

Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform

Published on: November 30, 2016

In Vitro Characterization of the Electrophysiological Properties of Colonic Afferent Fibers in Rats

In Vitro Characterization of the Electrophysiological Properties of Colonic Afferent Fibers in Rats

Published on: September 27, 2017

相关概念视频

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...

Irritable Bowel Syndrome III: Medical and Nursing Management

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.

Drugs for Treatment of Constipation-Predominant IBS

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...

Drugs for Treatment of Diarrhea-Predominant IBS

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...